V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220013193 | 220017741 | 1.75 | null | Disease modification (D) | 2017-07-31 | 2017-08-11 | Hydroxycarbamide | 2 | N | 220029400 | HYDROXYCARBAMIDE |
| 220013194 | 220007613 | 1.51 | 34.25 | Palliative (P) | 2016-11-04 | 2017-04-23 | Hydroxycarbamide | 02 | N | 220029410 | HYDROXYCARBAMIDE |
| 220013195 | 220007613 | 1.58 | 104.7 | Palliative (P) | 2014-11-24 | 2015-03-30 | Hydroxycarbamide | 02 | N | 220029410 | HYDROXYCARBAMIDE |
| 220013196 | 220007614 | 1.55 | 12.3 | Palliative (P) | null | 2013-06-09 | AML MyeChild | null | N | 220029416 | NOT MATCHED |
| 220013197 | 220007616 | null | 24.4 | Palliative (P) | 2013-10-30 | 2015-10-03 | DAUNORUBICIN + METHOTREXATE + RITUXIMAB + VINCRISTINE | 02 | N | 220029420 | NOT MATCHED |
| 220013198 | 220014193 | null | 68 | Disease modification (D) | 2017-03-20 | 2017-11-22 | Cytarabine Low Dose | 02 | N | 220029424 | CYTARABINE |
| 220013199 | 220014193 | 0 | null | Disease modification (D) | 2015-04-19 | 2015-04-19 | CYTARABINE | 02 | N | 220029424 | CYTARABINE |
| 220013200 | 220014193 | null | 58.3 | Disease modification (D) | 2013-09-27 | 2013-09-28 | Hydroxycarbamide | N | N | 220029424 | HYDROXYCARBAMIDE |
| 220013201 | 220014193 | 1.62 | 57.3 | Disease modification (D) | 2018-04-03 | 2018-04-03 | AML MyeChild 01 A Mitozantrone/Cytarabine | 2 | N | 220029424 | NOT MATCHED |
| 220013202 | 220007617 | 1.7 | 0 | Palliative (P) | 2013-09-29 | 2013-09-29 | Hydroxycarbamide | 02 | N | 220029428 | HYDROXYCARBAMIDE |
| 220013203 | 220007617 | null | 14.3 | Palliative (P) | 2015-03-25 | 2015-03-26 | AML Relapsed FLA - DaunoXome | N | N | 220029428 | NOT MATCHED |
| 220013204 | 220007617 | null | null | Palliative (P) | 2017-01-18 | 2017-01-19 | CYTARABINE | 02 | N | 220029428 | CYTARABINE |
| 220013205 | 220014195 | 1.81 | 83 | Palliative (P) | 2017-05-23 | 2017-05-24 | CYTARABINE | 02 | N | 220029439 | CYTARABINE |
| 220013206 | 220007620 | 1.7 | 12.4 | Palliative (P) | 2016-05-09 | 2016-05-18 | null | N | N | 220029442 | NOT MATCHED |
| 220013207 | 220007621 | 1.85 | 25.2 | Palliative (P) | 2013-10-26 | 2013-11-03 | AML MyeChild | 2 | N | 220029442 | NOT MATCHED |
| 220013208 | 220007625 | 1.73 | null | Palliative (P) | 2016-12-23 | 2017-01-01 | AML Downs HA | 02 | N | 220029447 | NOT MATCHED |
| 220013209 | 220007625 | 0 | 15.2 | Palliative (P) | 2018-01-24 | 2018-01-25 | null | N | N | 220029447 | NOT MATCHED |
| 220013210 | 220017747 | 1.87 | 87.5 | Palliative (P) | 2017-02-21 | 2017-02-23 | Hydroxycarbamide | 2 | N | 220029449 | HYDROXYCARBAMIDE |
| 220013211 | 220007626 | null | 115 | null | 2016-11-10 | 2016-12-22 | Cytarabine low (10to20mg/m2) IV/SC | null | N | 220029453 | CYTARABINE |
| 220013212 | 220007628 | 1.65 | null | Adjuvant (A) | 2014-01-20 | 2014-01-21 | CYTARABINE | 02 | N | 220029454 | CYTARABINE |
| 220013214 | 220014201 | 1.69 | 101 | Palliative (P) | 2017-10-06 | 2017-10-06 | Cytarabine Low Dose | 02 | N | 220029464 | CYTARABINE |
| 220013215 | 220007632 | 1.72 | 89.6 | Palliative (P) | 2015-09-13 | 2015-09-16 | CYTARABINE | N | N | 220029465 | CYTARABINE |
| 220013216 | 220007633 | null | 15.3 | Curative (C) | null | 2016-05-07 | null | N | N | 220029467 | NOT MATCHED |
| 220013217 | 220007637 | 1.76 | 20.4 | Curative (C) | null | 2015-10-18 | AML Interim Guidelines FLA -Ida | N | N | 220029470 | NOT MATCHED |
| 220013218 | 220007640 | 1.6 | 76 | Curative (C) | 2013-01-29 | 2013-02-09 | MERCAPTOPURINE + METHOTREXATE + Tretinoin | 02 | N | 220029470 | NOT MATCHED |
| 220013219 | 220007641 | 0 | null | Palliative (P) | 2016-02-14 | 2016-02-14 | Cytarabine Low Dose | N | N | 220029478 | CYTARABINE |
| 220013220 | 220007642 | 0 | 37.2 | null | 2017-03-25 | 2017-05-11 | APML Maintenance Mercaptopurine,Methotrexate,IT AraC | N | N | 220029485 | NOT MATCHED |
| 220013222 | 220007645 | null | 70.8 | Disease modification (D) | 2015-11-12 | 2015-11-13 | Hydroxycarbamide | N | N | 220029493 | HYDROXYCARBAMIDE |
| 220013223 | 220007646 | 0 | 11.5 | Disease modification (D) | 2016-07-05 | 2016-12-01 | FLUDARABINE + THIOTEPA + TREOSULFAN | N | N | 220029496 | NOT MATCHED |
| 220013225 | 220007647 | 0 | 91 | Palliative (P) | 2013-05-25 | 2013-07-11 | null | 2 | N | 220029500 | NOT MATCHED |
| 220013226 | 220007649 | 1.01 | 104.7 | Disease modification (D) | 2016-05-13 | 2016-05-14 | Hydroxycarbamide | N | null | 220029504 | HYDROXYCARBAMIDE |
| 220013227 | 220014209 | null | 62 | Disease modification (D) | 2015-11-23 | 2015-11-23 | Cytarabine Low Dose | N | null | 220029506 | CYTARABINE |
| 220013228 | 220007650 | 0 | 74.199 | Curative (C) | 2017-01-12 | 2017-01-12 | null | 02 | N | 220029507 | NOT MATCHED |
| 220013229 | 220007650 | 0 | 0 | null | null | 2015-02-26 | Hydroxycarbamide | 02 | N | 220029507 | HYDROXYCARBAMIDE |
| 220013230 | 220007650 | 1.81 | 103 | Palliative (P) | 2013-12-02 | 2013-12-02 | Hydroxycarbamide | null | N | 220029507 | HYDROXYCARBAMIDE |
| 220013231 | 220020887 | null | 66.5 | Curative (C) | 2013-07-18 | 2013-10-11 | Amsacrine + ANTITHYMOCYTE IMMUNOGLOBULIN (RABBIT) + BUSULFAN + CYTARABINE + FLUDARABINE | N | N | 220029514 | NOT MATCHED |
| 220013232 | 220007652 | 1.49 | 96.7 | Curative (C) | 2016-07-09 | 2016-07-11 | Cytarabine Low Dose | null | null | 220029514 | CYTARABINE |
| 220013233 | 220007653 | null | 63.3 | Palliative (P) | 2018-11-01 | 2018-11-08 | Cytarabine Low Dose | 2 | N | 220029520 | CYTARABINE |
| 220013234 | 220007653 | 1.53 | 93 | Palliative (P) | 2014-07-31 | 2014-08-01 | Cytarabine Intrathecal (any age) | N | null | 220029520 | CYTARABINE |
| 220013235 | 220017753 | 1.44 | 39.4 | Curative (C) | 2017-03-01 | 2017-03-22 | APML Consolidation III ATRA, Idarubicin, Cytarabine | Y | null | 220029522 | NOT MATCHED |
| 220013236 | 220019737 | 0.62 | 74.5 | Curative (C) | 2013-04-18 | 2014-04-15 | Cytarabine Low Dose | N | N | 220029522 | CYTARABINE |
| 220013237 | 220007654 | 1.68 | 15.2 | Palliative (P) | 2013-10-10 | 2013-10-10 | AML MyeChild 01 FLA-Idarubicin | 01 | N | 220029523 | NOT MATCHED |
| 220013238 | 220007654 | 0 | 76.4 | Palliative (P) | 2016-06-15 | 2016-06-21 | Cytarabine Low Dose | 02 | N | 220029523 | CYTARABINE |
| 220013239 | 220007656 | 0 | null | Curative (C) | 2013-04-02 | 2013-04-04 | CYTARABINE | N | N | 220029537 | CYTARABINE |
| 220013240 | 220007656 | 0 | 114 | Curative (C) | 2015-03-23 | 2015-03-23 | CYTARABINE | N | N | 220029537 | CYTARABINE |
| 220013241 | 220007657 | 1.71 | 12 | Palliative (P) | 2014-08-26 | 2014-08-27 | CYCLOPHOSPHAMIDE + CYTARABINE + ETOPOSIDE | 02 | N | 220029540 | NOT MATCHED |
| 220013242 | 220007657 | 0 | null | Palliative (P) | 2014-02-03 | 2014-02-03 | Cytarabine Low Dose | N | null | 220029540 | CYTARABINE |
| 220013244 | 220007659 | 1.58 | null | Palliative (P) | 2013-12-24 | 2013-12-24 | Hydroxycarbamide | 02 | N | 220029559 | HYDROXYCARBAMIDE |
| 220013245 | 220007659 | 1.62 | 0 | Palliative (P) | 2016-12-11 | 2017-01-24 | Hydroxycarbamide | N | N | 220029559 | HYDROXYCARBAMIDE |
| 220013246 | 220019740 | 1.57 | 46.5 | Palliative (P) | null | 2013-06-04 | CYTARABINE | N | Y | 220029568 | CYTARABINE |